CTRI/2020/10/028471尚未招募未知
Immunological Effect of the drug â??Immuneâ??- an Ayurveda medication in COVID-19 patients
GR Vishnu Sri0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Mild to Moderate COVID- 19 confirmed patients of age greater than 20 years and upto 58 years and willing to participate with consent
排除标准
- •Who are not willing to participate, with co-morbidities, pregnant and lactating women
研究者
相似试验
未知
不适用
Therapeutic effect of an immunosupp-ressive agent, mizoribine in patients with the progression of renal failure in diabetic nephropathyDiabetic nephropathyJPRN-UMIN000001824Okayama University40
已完成
4 期
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16
招募中
3 期
Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level studyCTRI/2020/06/025861Department of Ayush Uttarakhand
已完成
2 期
To study the effect of Swarnaprashan in reducing the frequency of illness in children by improving the immunity and increasing the body strength.CTRI/2021/05/033713ational Institute of Ayurveda Jaipur Rajasthan30
已完成
不适用
Investigational study on immunomodulatory effect of lenvatinib in clinical specimens - Future oriented approach for lenvatinib on tumor microenvironment and cancer regression (FLORENCE)Hepatocellular carcinomaJPRN-UMIN000044924Hiroshima University50